ClinicalTrials.gg
Enrolling by invitationNCT06520592CPAP OSAUpdated Oct 15, 2026

The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients

An interventional study of With AR guided CPAP therapy in Aherence, Physical Symptoms and Mental Health, sponsored by National Cheng-Kung University Hospital. Enrolling by invitation at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Health services research

How we know

Updated Oct 15, 2026Now Enrolling by invitationStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 45 studies in Psychological Well-Being with a site in Taiwan — 15 open to participants now, 16 under way, none of them phase 3. Psychological Well-Being · Taiwan.

Planned enrollment
30th of 40
60 · median 93
Started
2026
with 8 others
No phase
40 of 45
11 open now
Primary completion
2026-12
later than 7 of 15 live
Registered
16th of 45
by date
Lead sponsor
2 of 45
National Cheng-Kung University Hospital

Among the 45 studies in Psychological Well-Being with a site in Taiwan, this one is the 30th largest by planned enrollment of the 40 interventional ones that give a count, is one of 9 that started in 2026, is one of 40 with no phase, reaches primary completion later than 7 of the 15 other live ones, and was the 16th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

15 of the 45 studies in Psychological Well-Being with a site in Taiwan are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Psychological Well-Being with a site in Taiwan, or all of them as a file.
02

Study summary

The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are:

Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy.

Participants will:

  1. Take AR guided CPAP therapy or standard of care every day for 6 months
  2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3).
  3. Response their symptoms on each following time.
Read the detailed description

Participants will randomly assign to two group, for experimental group will be received AR guided CPAP therapy. In the control group will be received standard of care.

03

Conditions studied

  • Aherence
  • Physical Symptoms
  • Mental Health
  • Quality of Life

Keywords

  • Augmented Reality (AR)
  • continuous positive airway pressure (CPAP)
  • Adherence
  • Symptoms change
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (1) Diagnosed with moderate to severe obstructive sleep apnea (AHI≥15) through polysomnography (PSG).
  • (2) Age is equal to or greater than 20 years old or equal.

Exclusion criteria

Exclusion Criteria:

  • (1) individuals who have previously used positive pressure ventilators for treatment,
  • (2) those diagnosed with central sleep apnea,
  • (3) those with uncontrolled acute mental illness,
  • (4) terminally ill patients.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    With AR guided CPAP therapy

    OSA patientns were assigned to experimental group, they will be received AR guided CPAP therapy

    Behavioral: With AR guided CPAP therapy

  • No intervention
    Standard of care

    OSA patientns were assigned to stand of care group, they will be not received AR guided CPAP therapy

Interventions

  • BehavioralWith AR guided CPAP therapy

    Participants will received AR training course to utilize the AR guided CPAP therapy

06

What researchers measure

Primary outcomes

  1. The adherence of CPAP therapy

    Adherence refers to the patient's adherence to CPAP therapy, which means using CPAP for more than 70% of the total sleep time during the night, with a minimum duration of 4 hours. The calculation method involves dividing the number of days with CPAP use exceeding 4 hours by the total number of days and multiplying by 100 to obtain the average percentage of CPAP usage.

    Time frame: From enrollment to the end of treatment at 6 months

07

Study locations

1 site
08

References and documents

Publications

  • Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016 Aug 19;45(1):43. doi: 10.1186/s40463-016-0156-0. PubMed 27542595 ↗
  • Bakker JP, Weaver TE, Parthasarathy S, Aloia MS. Adherence to CPAP: What Should We Be Aiming For, and How Can We Get There? Chest. 2019 Jun;155(6):1272-1287. doi: 10.1016/j.chest.2019.01.012. Epub 2019 Jan 23. PubMed 30684472 ↗
  • Wiederhold BK. How Virtual Reality Is Changing the Reality of Aging. Cyberpsychol Behav Soc Netw. 2020 Mar;23(3):141-142. doi: 10.1089/cyber.2020.29176.bkw. No abstract available. PubMed 32150700 ↗
  • Chen YC, Frange C, Pan SS, Ng CM, Chen YH, Lin CY. Beyond the Mask-Psychological Discomfort as a Predictor of Early CPAP Nonadherence in Moderate-to-Severe OSA Patients: A Prospective Mixed-Methods Study. Nurs Res Pract. 2026 Apr 6;2026:9630236. doi: 10.1155/nrp/9630236. eCollection 2026. PubMed 41953147 ↗
  • Chen MC, Chen YC, Lin CY. Enhancing Adherence to Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Using Augmented Reality: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 May 6;14:e69757. doi: 10.2196/69757. PubMed 40327384 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 3 months is below that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: start Jun 2025 → Sep 2026, primary completion Dec 2025 → Dec 2026 and completion Jul 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2024
First posted
Jul 25, 2024
StartActual
Sep 24, 2026was Jun 2025
Primary completionEst.
Dec 31, 2026was Dec 2025
CompletionEst.
Dec 31, 2026was Jul 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Oct 15, 2026
Sites
1 site added, 1 site removed
Show site
  • National Cheng Kung University Hospital · Tainan, Taiwan
Show 1 removed
  • National Cheng Kung University Hospital · Tainan, Taiwan
Oct 15, 2026
Start date
Jun 20, 2025→Sep 24, 2026 (actual)
Oct 15, 2026
Primary completion
Dec 31, 2025→Dec 31, 2026
Oct 15, 2026
Study completion
Jul 31, 2026→Dec 31, 2026
Oct 15, 2026
Publications
2 publications citing this study linked from PubMed, e.g. PubMed 41953147 ↗
Oct 15, 2026
Contact
No study contact listed any more: removed y•••@gmail.com · •••2000
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Not yet recruiting→Enrolling by invitation
    Publications 2 publications citing this study linked from PubMed, e.g. PubMed 41953147 ↗
    1 site added, 1 site removed
    Show site
    • National Cheng Kung University Hospital · Tainan, Taiwan
    Show 1 removed
    • National Cheng Kung University Hospital · Tainan, Taiwan
    Start date Jun 20, 2025→Sep 24, 2026 (now actual)
    Primary completion Dec 31, 2025→Dec 31, 2026
    Study completion Jul 31, 2026→Dec 31, 2026
    Contact No study contact listed any more: removed y•••@gmail.com · •••2000
    + 3 other changes: verification date, oversight details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06520592
Responsible party
Chen, Yen-Chin (Associate Professor, National Sun Yat-sen University) — Principal investigator
First posted
Jul 25, 2024
Start date
Sep 24, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 15, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion